🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Erlotinib attacks a part of cancer cells that helps them live and grow. Stu...
Status
Terminated
Location
Vanderbilt-Ingram Oncology Cool Springs
Start Date
2010-05
Trial ID
NCT01205685
The primary objective is to evaluate whether Zoladex 10.8 mg (12-weekly) is...
Status
Completed
Location
Research Site
Start Date
2006-04
Trial ID
NCT00322348
Treatments Being Tested
Aim of this study is to demonstrate the bioequivalence of single subcutaneo...
Status
Completed
Location
Multiple Locations
Start Date
2009-02
Trial ID
NCT02592031
This is a multi-center, retrospective-prospective, observational, active-co...
Status
Completed
Location
Research Site
Start Date
2022-01-06
Trial ID
NCT05184257
This study will recruit 168 patients in approximately 20 study centres in C...
Status
Withdrawn
Location
Research Site
Start Date
2020-03-31
Trial ID
NCT03658213
Treatments Being Tested
This is a randomized, open-label and parallel phase I study to compare phar...
Status
Completed
Location
Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Start Date
2021-02-04
Trial ID
NCT05140512
Treatments Being Tested
The purpose of this study is to determine the efficacy and tolerance of the...
Status
Completed
Location
Multiple Locations
Start Date
2001-12
Trial ID
NCT00235937
Treatments Being Tested
A two arm, multi centric, randomized, open label, parallel, multiple dose p...
Status
Terminated
Location
Mahatma Gandhi Cancer Hospital & Research Institute
Start Date
2020-10-30
Trial ID
NCT03936933
Treatments Being Tested
A phase I, randomized, open-label and active-control study to assess the PK...
Status
Completed
Location
Pinnacle Research LLC
Start Date
2017-12-22
Trial ID
NCT03450109
This is a multicenter, randomized, open-label, active comparator-controlled...
Status
Completed
Location
Zhejiang Cancer Hospital
Start Date
2020-10-15
Trial ID
NCT05110170
Treatments Being Tested